Dose Finding in Oncology Trials Guided by Ordinal Toxicity Grades Using Continuous Dose Levels
We present a Bayesian adaptive design for dose finding in oncology trials with application to a first-in-human trial. The design is based on the escalation with overdose control principle and uses an intermediate grade 2 toxicity in addition to the traditional binary indicator of dose-limiting toxic...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI AG
2024-08-01
|
| Edice: | Entropy |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/1099-4300/26/8/687 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|